Cargando…

Cardiovascular risk in newly diagnosed type 2 diabetes patients in India

BACKGROUND: Type 2 diabetes mellitus (T2DM) worldwide continues to increase, in particular in India. Early T2DM diagnosis followed by appropriate management will result in more cardiovascular event free life years. However, knowledge of the cardiovascular profile of newly diagnosed T2DM patients is...

Descripción completa

Detalles Bibliográficos
Autores principales: Unnikrishnan, A. G., Sahay, R. K., Phadke, Uday, Sharma, S. K., Shah, Parag, Shukla, Rishi, Viswanathan, Vijay, Wangnoo, S. K., Singhal, Santosh, John, Mathew, Kumar, Ajay, Dharmalingam, Mala, Jain, Subodh, Shaikh, Shehla, Verberk, Willem J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8970505/
https://www.ncbi.nlm.nih.gov/pubmed/35358208
http://dx.doi.org/10.1371/journal.pone.0263619
_version_ 1784679471228387328
author Unnikrishnan, A. G.
Sahay, R. K.
Phadke, Uday
Sharma, S. K.
Shah, Parag
Shukla, Rishi
Viswanathan, Vijay
Wangnoo, S. K.
Singhal, Santosh
John, Mathew
Kumar, Ajay
Dharmalingam, Mala
Jain, Subodh
Shaikh, Shehla
Verberk, Willem J.
author_facet Unnikrishnan, A. G.
Sahay, R. K.
Phadke, Uday
Sharma, S. K.
Shah, Parag
Shukla, Rishi
Viswanathan, Vijay
Wangnoo, S. K.
Singhal, Santosh
John, Mathew
Kumar, Ajay
Dharmalingam, Mala
Jain, Subodh
Shaikh, Shehla
Verberk, Willem J.
author_sort Unnikrishnan, A. G.
collection PubMed
description BACKGROUND: Type 2 diabetes mellitus (T2DM) worldwide continues to increase, in particular in India. Early T2DM diagnosis followed by appropriate management will result in more cardiovascular event free life years. However, knowledge of the cardiovascular profile of newly diagnosed T2DM patients is still limited. The aim of this study was to understand the extent of cardiovascular disease (CVD) risk of newly diagnosed T2DM patients in India. METHODS: A cross sectional observational study was conducted to evaluate clinical laboratory and socio-demographic parameters of 5,080 newly diagnosed T2DM patients (48.3 ± 12.8 years of age; 36.7% female). In addition, we determined their cardiovascular risk according to the guidelines of the Lipid Association of India (LAI) and the criteria of the QRISK3 score. RESULTS: Of the newly T2DM diagnosed patients in India 2,007(39.5%) were classified as “High risk” and 3,073 (60.5%) were classified as “Very high risk” based on LAI criteria. On average, patients had 1.7 ± 0.9 major atherosclerotic cardiovascular disease (ASCVD) risk factors. Low HDL-C value was the most frequent major risk (2,823; 55.6%) followed by high age (2,502; 49.3%), hypertension (2,141; 42.1%), smoking/tobacco use (1,078; 21.2%) and chronic kidney disease stage 3b or higher (568; 11.2%). In addition, 4,192 (82.5%) patients appeared to have at least one cholesterol abnormality and, if the latest LAI recommendations are applied, 96.5% (4,902) presented with lipid values above recommended targets. Based on the QRISK3 calculation Indian diabetes patients had an average CVD risk of 15.3 ± 12.3%, (12.2 ± 10.1 vs. 17.1 ± 13.5 [p<0.001] for females and males, respectively). CONCLUSIONS: Newly diagnosed Indian T2DM patients are at high ASCVD risk. Our data therefore support the notion that further extension of nationwide ASCVD risk identification programs and prevention strategies to reduce the occurrence of cardiovascular diseases are warranted.
format Online
Article
Text
id pubmed-8970505
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-89705052022-04-01 Cardiovascular risk in newly diagnosed type 2 diabetes patients in India Unnikrishnan, A. G. Sahay, R. K. Phadke, Uday Sharma, S. K. Shah, Parag Shukla, Rishi Viswanathan, Vijay Wangnoo, S. K. Singhal, Santosh John, Mathew Kumar, Ajay Dharmalingam, Mala Jain, Subodh Shaikh, Shehla Verberk, Willem J. PLoS One Research Article BACKGROUND: Type 2 diabetes mellitus (T2DM) worldwide continues to increase, in particular in India. Early T2DM diagnosis followed by appropriate management will result in more cardiovascular event free life years. However, knowledge of the cardiovascular profile of newly diagnosed T2DM patients is still limited. The aim of this study was to understand the extent of cardiovascular disease (CVD) risk of newly diagnosed T2DM patients in India. METHODS: A cross sectional observational study was conducted to evaluate clinical laboratory and socio-demographic parameters of 5,080 newly diagnosed T2DM patients (48.3 ± 12.8 years of age; 36.7% female). In addition, we determined their cardiovascular risk according to the guidelines of the Lipid Association of India (LAI) and the criteria of the QRISK3 score. RESULTS: Of the newly T2DM diagnosed patients in India 2,007(39.5%) were classified as “High risk” and 3,073 (60.5%) were classified as “Very high risk” based on LAI criteria. On average, patients had 1.7 ± 0.9 major atherosclerotic cardiovascular disease (ASCVD) risk factors. Low HDL-C value was the most frequent major risk (2,823; 55.6%) followed by high age (2,502; 49.3%), hypertension (2,141; 42.1%), smoking/tobacco use (1,078; 21.2%) and chronic kidney disease stage 3b or higher (568; 11.2%). In addition, 4,192 (82.5%) patients appeared to have at least one cholesterol abnormality and, if the latest LAI recommendations are applied, 96.5% (4,902) presented with lipid values above recommended targets. Based on the QRISK3 calculation Indian diabetes patients had an average CVD risk of 15.3 ± 12.3%, (12.2 ± 10.1 vs. 17.1 ± 13.5 [p<0.001] for females and males, respectively). CONCLUSIONS: Newly diagnosed Indian T2DM patients are at high ASCVD risk. Our data therefore support the notion that further extension of nationwide ASCVD risk identification programs and prevention strategies to reduce the occurrence of cardiovascular diseases are warranted. Public Library of Science 2022-03-31 /pmc/articles/PMC8970505/ /pubmed/35358208 http://dx.doi.org/10.1371/journal.pone.0263619 Text en © 2022 Unnikrishnan et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Unnikrishnan, A. G.
Sahay, R. K.
Phadke, Uday
Sharma, S. K.
Shah, Parag
Shukla, Rishi
Viswanathan, Vijay
Wangnoo, S. K.
Singhal, Santosh
John, Mathew
Kumar, Ajay
Dharmalingam, Mala
Jain, Subodh
Shaikh, Shehla
Verberk, Willem J.
Cardiovascular risk in newly diagnosed type 2 diabetes patients in India
title Cardiovascular risk in newly diagnosed type 2 diabetes patients in India
title_full Cardiovascular risk in newly diagnosed type 2 diabetes patients in India
title_fullStr Cardiovascular risk in newly diagnosed type 2 diabetes patients in India
title_full_unstemmed Cardiovascular risk in newly diagnosed type 2 diabetes patients in India
title_short Cardiovascular risk in newly diagnosed type 2 diabetes patients in India
title_sort cardiovascular risk in newly diagnosed type 2 diabetes patients in india
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8970505/
https://www.ncbi.nlm.nih.gov/pubmed/35358208
http://dx.doi.org/10.1371/journal.pone.0263619
work_keys_str_mv AT unnikrishnanag cardiovascularriskinnewlydiagnosedtype2diabetespatientsinindia
AT sahayrk cardiovascularriskinnewlydiagnosedtype2diabetespatientsinindia
AT phadkeuday cardiovascularriskinnewlydiagnosedtype2diabetespatientsinindia
AT sharmask cardiovascularriskinnewlydiagnosedtype2diabetespatientsinindia
AT shahparag cardiovascularriskinnewlydiagnosedtype2diabetespatientsinindia
AT shuklarishi cardiovascularriskinnewlydiagnosedtype2diabetespatientsinindia
AT viswanathanvijay cardiovascularriskinnewlydiagnosedtype2diabetespatientsinindia
AT wangnoosk cardiovascularriskinnewlydiagnosedtype2diabetespatientsinindia
AT singhalsantosh cardiovascularriskinnewlydiagnosedtype2diabetespatientsinindia
AT johnmathew cardiovascularriskinnewlydiagnosedtype2diabetespatientsinindia
AT kumarajay cardiovascularriskinnewlydiagnosedtype2diabetespatientsinindia
AT dharmalingammala cardiovascularriskinnewlydiagnosedtype2diabetespatientsinindia
AT jainsubodh cardiovascularriskinnewlydiagnosedtype2diabetespatientsinindia
AT shaikhshehla cardiovascularriskinnewlydiagnosedtype2diabetespatientsinindia
AT verberkwillemj cardiovascularriskinnewlydiagnosedtype2diabetespatientsinindia